Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2006; 12(5): 703-708
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.703
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.703
Figure 1 4×106 of GIST-T1 cells were treated with STI571 (1 μg/mL) for 1 h.
Treated cells were lysed in RIPA buffer and immunoprecipitation with anti-c-KIT antibody as described in “Materials and methods”. Western blotting was performed using anti-phosphotyrosine antibody (upper panel) or anti-c-KIT antibody (lower panel). Lane 1, non-treated; lane 2, STI571 1 μg/mL. WB, Western blot; IP, immunoprecipitation.
- Citation: Jin T, Nakatani H, Taguchi T, Nakano T, Okabayashi T, Sugimoto T, Kobayashi M, Araki K. STI571 (Glivec) suppresses the expression of vascular endothelial growth factor in the gastrointestinal stromal tumor cell line, GIST-T1. World J Gastroenterol 2006; 12(5): 703-708
- URL: https://www.wjgnet.com/1007-9327/full/v12/i5/703.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i5.703